Skip to main content

Table 1 Investigators and institutions

From: Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

No.

Institutions

Investigators

1

Ohtsuka Eye Hospital

Makoto Higuchi

2

Mitani Eye Clinic

Kiichiro Mitani

3

Muramatsu Eye Clinic

Tomoyuki Muramatsu

4

Nakajima Eye Clinic

Toru Nakajima

5

Kikukawa Eye Clinic

Koichiro Ikeda

6

Tokai Eye Clinic

Yoshihide Nakai

7

Kitano Hospital

Isao Saito

8

Nishi Eye Hospital

Hiroki Iwanishi

9

Hirota Eye Clinic

Atsushi Hirota

10

Ohshima Hospital of Ophthalmology

Nobuyuki Yabe

11

Hayashi Eye Hospital

Ken Hayashi